Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof

Peptide inhibitors targeting the CXCL12/HMGB1 interaction and uses thereof

US Patent 12098175 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for the treatment of tumors2025
Methods using fingerprint and evolution analysis2022
Dual inhibitor compounds for use in the treatment of neurodegenerative disorders2018
Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase 2017
Multitarget FAAH and COX inhibitors and therapeutical uses thereof2017
2,5-bis-diamine-[1,4]benzoquinonic derivatives, useful for the treatment of alzh2009